spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  atherectomy 

 HSMN NewsFeed - 6 Oct 2021
BD Announces 510(k) Clearance of Expanded Indications for the Rotarex(TM) Atherectomy System
Devices Interventional FDA
 HSMN NewsFeed - 10 Jul 2018
Avinger Appoints Jaafer Golzar, MD, FACC, FSCAI, as Chief Medical Officer
Devices Interventional Personnel
 HSMN NewsFeed - 6 Sep 2017
Gardia Medical Demonstrates Enhanced Safety in Lower Extremity Interventions
Devices Interventional
 HSMN NewsFeed - 28 Jun 2017
Philips to acquire Spectranetics for $1.7B
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 26 Apr 2017
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
Devices Interventional Drug Delivery
 HSMN NewsFeed - 16 Aug 2016
Cardiovascular Systems Names Scott Ward as CEO
Devices Cardiology Personnel
 HSMN NewsFeed - 2 Sep 2015
Atossa Genetics, Inc. Announces Appointment of Scott Youmans as Chief Operating Officer
Devices Diagnostics Personnel
 HSMN NewsFeed - 12 Aug 2015
Avinger, Inc. Announces Early 510(k) Filing for Pantheris(TM)
Devices Interventional FDA
 HSMN NewsFeed - 29 Jul 2015
Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology
Devices Interventional
 HSMN NewsFeed - 9 Jun 2015
CMS Further Improves Reimbursement for Lutonix DCB for Outpatient Use
Devices Interventional Reimbursement
 HSMN NewsFeed - 20 Apr 2015
Cardiovascular Systems Receives FDA Clearance for New Peripheral Diamondback Device
Devices Interventional FDA
 HSMN NewsFeed - 27 Jan 2015
Spectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon Assets From Covidien
Devices Interventional Acquisitions
 HSMN NewsFeed - 4 Sep 2014
EndoCross Receives CE Mark Approval for the ENABLER-C Coronary Catheter System for the Crossing of Coronary Chronic Total Occlusions
Devices INterventional Cardiology Regulatory
 HSMN NewsFeed - 2 Sep 2014
Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 19 Aug 2014
Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Jun 2014
Cardiovascular Systems Announces Plans for New Corporate Headquarters
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2014
Boston Scientific Announces Definitive Agreement To Acquire Interventional Division Of Bayer AG
Devices Interventional Acquisitions
 HSMN NewsFeed - 12 Mar 2014
Cardiovascular Systems Announces First Peripheral Arterial Disease Case Treated with New, Low-Profile, 60cm Diamondback Peripheral System
Devices Interventional
 HSMN NewsFeed - 10 Mar 2014
Cardiovascular Systems Receives FDA Clearance for Low Profile, 60cm Diamondback Devices Designed to Expand the Treatment of Peripheral Artery Disease (PAD)
Devices Interventional FDA
 HSMN NewsFeed - 3 Dec 2013
Physicians Throughout U.S. Using Cardiovascular Systems’ New Technology to Treat Coronary Artery Disease
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 22 Oct 2013
Cardiovascular Systems, Inc. Receives Coronary FDA Approval
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 15 Mar 2013
Cardiovascular Systems Completes PMA Submission of Orbital Atherectomy System for Coronary Artery Disease Treatment
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 29 Jan 2013
Spectranetics Announces Expansion Into Japan Peripheral Intervention Market
Devices Interventional Regulatory
 HSMN NewsFeed - 24 Jan 2013
Final Results of Spectranetics Study Supports Successful Use of Laser Atherectomy for Treating Patients With Peripheral In-Stent Restenosis
Devices Interventional
 HSMN NewsFeed - 8 Oct 2012
Spectranetics Announces U.S. Launch of the TAPAS(TM) Catheter and Preclinical Animal Data on Drug Uptake in Peripheral Vessels
Devices Interventional Drug Delivery Distribution
 HSMN NewsFeed - 10 Jul 2012
Avinger Raises $33 Million in Series D Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 2 Feb 2012
Spectranetics Announces Interim Results from German Study Treating Patients with Peripheral In-Stent Restenosis
Devices Interventional
 HSMN NewsFeed - 24 Jan 2012
Spectranetics Strengthens Peripheral Vascular Portfolio with a Partnership to Distribute the TAPAS™ Catheter
Devices Distribution
 HSMN NewsFeed - 8 Sep 2011
Angioslide Announces the European Launch of New 300 mm Long Device Allowing Treatment of Entire Superficial Femoral Artery(SFA) with One Device
Devices Interventional
 HSMN NewsFeed - 12 Jul 2011
Spectranetics Appoints Scott Drake as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 13 Jun 2011
Pathway Medical Technologies Expands JETSTREAM G3 SF Family With FDA 510(k) Clearance for 1.6 mm Catheter
Devices Interventional FDA
 HSMN NewsFeed - 31 May 2011
Spectranetics Introduces First Advanced System for Simulation of Peripheral Vascular Arterial Occlusions
Devices Interventional
 HSMN NewsFeed - 7 Apr 2011
Spectranetics to Initiate Landmark Randomized Study of Laser Treatment for Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 6 Apr 2011
Spectranetics Announces Approval of LLD in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 28 Mar 2011
Pathway Medical Technologies Announces Enrollment of First Patient in JETSTREAM G3 Calcium Study
Devices Interventional
 HSMN NewsFeed - 17 Mar 2011
Cardiovascular Systems Receives FDA 510(k) Marketing Clearance for Stealth 360°(TM) Orbital PAD System
Devices Interventional FDA
 HSMN NewsFeed - 11 Feb 2011
Cardiovascular Systems Files Special 510(k) for Stealth 360°(TM) Orbital Pad System
Devices Interventional FDA
 HSMN NewsFeed - 20 Jan 2011
Spectranetics Receives FDA Approval for Site Change Related to Manufacturing of CVX-300(R) Laser System
Devices FDA
 HSMN NewsFeed - 7 Oct 2010
Spectranetics Announces Retirement of Chairman and CEO Emile J. Geisenheimer
Devices Cardiology Personnel
 HSMN NewsFeed - 20 Sep 2010
Vascular Solutions and Shepherd Scientific Announce U.S. Distribution of Angio Assist and Teirstein Edge Products
Devices Interventional Distribution
 HSMN NewsFeed - 3 Aug 2010
Cardiovascular Systems Launches Diamondback Predator 360° PAD System
Devices Interventional
 HSMN NewsFeed - 20 Jul 2010
Spectranetics Announces Reimbursement Approval for Laser-Assisted Lead Extraction in Japan
Devices Cardiology Reimbursement
 HSMN NewsFeed - 21 Jun 2010
Pathway Medical Technologies Receives FDA 510(k) Clearance for JETSTREAM G3 SF Atherectomy System
Devices Interventional FDA
 HSMN NewsFeed - 10 Jun 2010
Spectranetics Plans Randomized Clinical Trial for In-Stent Restenosis
Devices Interventional
 HSMN NewsFeed - 24 Mar 2010
Innovative Vascular Catheterization Approach Offers New Hope
Devices Drug Delivery Interventional
 HSMN NewsFeed - 14 Jan 2010
Cardiovascular Systems Receives Conditional IDE Approval for ORBIT II Coronary Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Jan 2010
Pathway Medical Technologies Receives FDA 510(k) Clearance for JETSTREAM G3 Atherectomy System
Devices Interventional FDA
 HSMN NewsFeed - 13 Jan 2010
Published Study Demonstrates Effectiveness of Spectranetics Turbo-Booster(R) for Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 8 Jan 2010
Mark Page Appointed Vice President, Marketing for FlowCardia, Inc.
Devices Interventional Personnel
 HSMN NewsFeed - 14 Dec 2009
Pathway Medical Technologies Receives CE Mark for the Jetstream G2 NXT
Devices Interventional Regulatory
 HSMN NewsFeed - 3 Dec 2009
Spectranetics Announces FDA Clearance of VisiSheath Dilator Sheath, New Lead Management Device
Devices Cardiology FDA
 HSMN NewsFeed - 6 Oct 2009
FlowCardia, Inc. Launches FlowMate(TM) Injector to Optimize Performance of CROSSER(R) CTO Recanalization Catheter
Devices Interventional
 HSMN NewsFeed - 29 Sep 2009
Spectranetics Submits 510(k) Application to Food and Drug Administration Seeking Clearance for the Treatment of In-Stent Restenosis in the Legs
Devices Interventional
 HSMN NewsFeed - 22 Sep 2009
Pathway Medical Technologies Sees 172 Percent Growth over Last 2 Quarters with Jetstream Revascularization Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Aug 2009
Pathway Medical Technologies Introduces Jetstream G2 NXT
Devices Interventional
 HSMN NewsFeed - 23 Jul 2009
FlowCardia, Inc. Appoints Chris Barys to Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 15 Jul 2009
Spectranetics Announces First Human Uses of Turbo-Tandem System
Devices Interventional
 HSMN NewsFeed - 9 Jul 2009
Spectranetics Announces FDA Clearance to Market Turbo-Tandem System
Devices Interventional FDA
 HSMN NewsFeed - 25 Jun 2009
Spectranetics Names Jason Hein Senior VP, Sales, Marketing and Product Development
Devices Personnel
 HSMN NewsFeed - 23 Jun 2009
Spectranetics Receives CE Mark Approval for ThromCat(R)XT
Devices Interventional Regulatory
 HSMN NewsFeed - 5 May 2009
Spectranetics Makes Pre-IDE Submission to FDA for the Treatment of In-Stent Restenosis in the Legs
Devices Interventional
 HSMN NewsFeed - 4 May 2009
Morph AccessPro Receives FDA Clearance
Devices Interventional FDA
 HSMN NewsFeed - 2 Feb 2009
Pathway Medical Technologies Receives FDA 510(K) Clearance for Jetstream G2 System
Devices Interventional FDA
 HSMN NewsFeed - 29 Jan 2009
Spectranetics Announces Executive Appointments to Further Enhance Compliance Programs
Devices Personnel
 HSMN NewsFeed - 21 Jan 2009
Spectranetics Reports on 12-Month CELLO Data at LINC Meeting in Leipzig, Germany
Devices Interventional
 HSMN NewsFeed - 16 Dec 2008
Bioheart, Inc. Announces Plans to Divest Non-Core Products to Increase Focus On Heart Failure Treatments
Devices Regenerative Medicine Cardiology
 HSMN NewsFeed - 4 Nov 2008
Cardiovascular Systems Signs Merger Agreement
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 22 Oct 2008
Spectranetics Appoints Company Chairman, Emile J. Geisenheimer, as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 8 Oct 2008
Paul Buckman Joins Pathway Medical Technologies as President and CEO, Tom Clement Named Chairman of the Board
Devices Interventional Personnel
 HSMN NewsFeed - 17 Sep 2008
Pathway Medical Technologies Announces First U.S. Patient Treated With Jetstream(TM) Pathway PV(TM) Atherectomy System
Devices Interventional
 HSMN NewsFeed - 15 Sep 2008
Spectranetics Provides Update on VIVA II: SALVAGE Trial
Devices Interventional
 HSMN NewsFeed - 5 Sep 2008
Pathway Medical Technologies Receives FDA Clearance for Jetstream(TM) Pathway PV(TM) Atherectomy System
Devices Interventional FDA
 HSMN NewsFeed - 27 Aug 2008
Spectranetics Announces First Laser Lead Extraction Procedures in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 13 Aug 2008
Spectranetics Takes Steps Targeted at Accelerating Vascular Intervention Growth
Devices Interventional Personnel
 HSMN NewsFeed - 7 Jul 2008
Spectranetics Appoints Michael Voss as Vice President and General Manager of Vascular Intervention Business
Devices Interventional Personnel
 HSMN NewsFeed - 2 Jun 2008
Spectranetics Announces Closing of Transaction to Acquire Endovascular Business of Kensey Nash
Devices Interventional Acquisitions
 HSMN NewsFeed - 13 May 2008
Spectranetics Acquires Endovascular Business of Kensey Nash
Devices Interventional Acquisitions
 HSMN NewsFeed - 13 May 2008
Kensey Nash Announces Sale of Endovascular Business and Strategic Partnership With Spectranetics
Devices Interventional Acquisitions
 HSMN NewsFeed - 15 Apr 2008
Pathway Medical Technologies, Inc. Secures $24.5 Million Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 25 Feb 2008
First Patient Enrolled in Study Evaluating Performance of Spectranetics Laser Ablation Followed by GORE VIABAHN(R) Endoprosthesis with Heparin Bioactive Surface
Devices Interventional
 HSMN NewsFeed - 30 Jan 2008
Iroko Pharmaceuticals Acquires Rights to Cardiovascular Product from Merck & Co., Inc.
Biopharmaceuticals Cardiology Acquisitions
 HSMN NewsFeed - 9 Oct 2007
Spectranetics Receives Reimbursement Approval in Belgium for Lead Removal and Peripheral Atherectomy Products
Devices Interventional Reimbursement
 HSMN NewsFeed - 4 Oct 2007
ev3 and FoxHollow Technologies Announce Completion of Merger
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 24 Sep 2007
New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
Devices Interventional FDA
 HSMN NewsFeed - 20 Aug 2007
Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
Devices Interventional Personnel
 HSMN NewsFeed - 31 Jul 2007
Pathway Medical Adds Medical Device Veteran Paul Buckman to Board of Directors, Appoints Vice President of Manufacturing
Devices Interventional Personnel
 HSMN NewsFeed - 27 Jul 2007
Positive Aggrastat(R) Results Versus Integrilin(R) Featured in American Heart Journal
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 23 Jul 2007
ev3 And FoxHollow To Merge In Transaction Creating A Global Leader In Endovascular Device Market
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 12 Jul 2007
Spectranetics Receives FDA Clearance for Expanded Labeling for TURBO Elite
Devices Interventional FDA
 HSMN NewsFeed - 2 Jul 2007
Spectranetics Receives FDA Clearance to Market TURBO-Booster
Devices FDA
 HSMN NewsFeed - 20 Feb 2007
Spectranetics Announces Preliminary Patent Litigation Verdict
Devices Litigation
 HSMN NewsFeed - 12 Feb 2007
Spectranetics Hires Jeffrey Deming as New Vice President of Quality Assurance and Regulatory Compliance
Devices Personnel
 HSMN NewsFeed - 3 Jan 2007
Spectranetics Laser System Used in Neurovascular Surgery for First Time in U.S.
Devices Neurosurgery
 HSMN NewsFeed - 4 Oct 2006
Spectranetics Receives Clearance to Market TURBO elite Product Line
Devices Interventional
 HSMN NewsFeed - 18 Sep 2006
FDA Approves Center Expansion of Cardiovascular Systems, Inc. Clinical Trial of the Orbital Atherectomy System
Devices Interventional FDA
 HSMN NewsFeed - 20 Jul 2006
Spectranetics Announces First Patient Enrolled in CELLO Trial
Devices Interventional
 HSMN NewsFeed - 19 Jul 2006
FDA Approves Expansion of Cardiovascular Systems Inc. Clinical Trial of the Orbital Atherectomy System for Treatment of Peripheral Vascular Stenosis (OASIS)
Devices Interventional
 HSMN NewsFeed - 27 Jun 2006
Peripheral Rinspiration(R) Catheter System Prominently Featured at Mount Sinai Live Cardiovascular Symposium
Devices Interventional
 HSMN NewsFeed - 1 Jun 2006
Kerberos Completes First Clinical Cases with New Peripheral Rinspiration(R) System
Devices
 HSMN NewsFeed - 19 May 2006
Spectranetics CLiRpath(R) TURBO-Booster(TM) Featured in Live Case at EuroPCR
Devices Interventional
 HSMN NewsFeed - 11 May 2006
Boston Scientific Announces Appointment of Donald Baim, M.D., as Chief Medical and Scientific Officer
Devices Interventional Cardiology Personnel
Return to NewsFeed  

 Additional items found! 65

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 65 additional stories matching:
atherectomy
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.